arrow
K

Kisato Nosaka

Kumamoto University Hospital
H指数:37
被引数:6,395

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Residual Disease Localization Before Allogeneic Hematopoietic Stem Cell Transplantation on Outcomes in Adult T-Cell Leukemia-Lymphoma

异基因造血干细胞移植前残留病灶定位对成人T细胞白血病-淋巴瘤预后的影响

2026-09-290
PRE
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma

一项CHOP联合抗CCR4抗体mogamulizumab治疗老年成人T细胞白血病/淋巴瘤患者的II期临床试验

Blood
IF23.1
2025-05-190
PRE
Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations
2023-12-122
OAAI
Clinical landscape of TP73 structural variants in ATL patients
LEUKEMIA
IF13.4
2023-10-201
OAAI
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
2023-02-169
OAAI
Landscape of immunoglobulin heavy chain γ gene class switch recombination in patients with adult T-cell leukemia-lymphoma
2022-11-240
OAAI
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
2022-04-1416
OAAI
A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial
2021-02-1610
OA
Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma

超高灵敏度HBsAg检测可以诊断淋巴瘤患者利妥昔单抗治疗后的HBV再激活

2020-08-0116
PREAI
The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach
2019-10-0149
OAAI
Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results
2017-09-0128
OAAI